Impact of oral submucous fibrosis on chemotherapy-induced mucositis for head and neck cancer in a geographic area in which betel quid chewing is prevalent

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 5, 1999, Pages 485-488

  Wang, Hung Ming ^a   Wang, Cheng Hsu ^a   Chen, Jen Shi ^a   Su, Cheng Lung ^b   Liao, Chun Ta ^b   Chen, I How ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Lin Kou Medical Center   (Taiwan)

Author keywords

Betel quid; Chemotherapy; Head and neck neoplasms; Mucositis; Oral submucous fibrosis

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINATE CALCIUM; METHOTREXATE;

ADULT; AGED; ARTICLE; BETEL NUT; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIBROSIS; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; MOUTH MUCOSA; MUCOSA INFLAMMATION; RISK FACTOR; TAIWAN;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARECA; ASIA, SOUTHEASTERN; CISPLATIN; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; ORAL SUBMUCOUS FIBROSIS; PLANTS, MEDICINAL; STOMATITIS; TAIWAN;

EID: 0033503868     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199910000-00013     Document Type: Article

References (28)

1. Kish J, Drelichman A, Jacobs J, et al. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 1982:66: 471-6.
2. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85:95-111.
3. Schantz SP, Harrison LB, Hong WK. Cancer of head and neck. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: principles & practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1993: 574-630.
4. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-90.
5. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III Trial. J Natl Cancer Inst 1996;88:890-9.
6. Berger AM, Kilroy TJ. Adverse effects of treatment: oral complications. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: principles & practice of oncology. 5th ed. Philadelphia: JB Lippincott, 1997:2714-20.
7. Wang HM, Wang CH, Chen JS, et al. Cisplatin and 5-FU as neoadjuvant chemotherapy: predicting response in head and neck squamous cell cancer. J Formos Med Assoc 1995;94:87-94.
8. Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancer: a study by the Gruppo di Studio sui Tumori della testa e del Collo. J Natl Cancer Inst 1994;86:265-72.
9. Spaulding MB, Fischer SG, Wolf GT, and the Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. Tumor response, toxicity, and survival after neoadjuvant organpreserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 1994;12:1592-9.
10. Shiau YY, Kwan HW, Mich AA. Submucous fibrosis in Taiwan. Oral Surg Oral Med Oral Pathol 1979;47:453-7.
11. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
12. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott, 1992.
13. Ko YC, Huang YL, Lee CH, et al. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995;24:450-3.
14. Chong KM. Betel nut chewing and mouth cancer in Taiwan. Observation of the oral mucosa in the betel nut chewers. J Formos Med Assoc 1966;65:79-85.
15. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formos Med Assoc 1976;75:497-505.
16. Department of Health, the Executive Yuan, R.O.C. Cancer registry annual report in Taiwan area, 1994. June 1997.
17. Pillai R, Balaram P, Reddiar KS. Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer. Cancer 1992;69:2011-20.
18. Murti PR, Bhonsle RB, Gupta PC, et al. Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med 1995;24:145-52.
19. Harvey W, Scutt A, Meghji S, Canniff JP. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 1986;31:45-9.
20. Kuttan R, Donnelly PV, Di Ferrante N. Collagen treated with catechin becomes resistant to the action of mammalian collagenase. Experientia 1981;37:221-3.
21. Jeng JH, Kuo MYP, Hahn LJ. Chemical carcinogenesis of the native betel quid in Taiwan. In: Monographs of the 88th Scientific Congress & Annual Meeting of Formosan Medical Association. Taipei. 1995.
22. Fidler P, Loprinzi CL, O'Fallon JR, et al. Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer 1996;77:522-5.
23. Rocke LK, Loprinzi CL, Lee JK, et al. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related mucositis. Cancer 1993;72:2234-8.
24. Chiang CP, Kuo MYP, Wang CT, et al. Oral submucous fibrosis. In: Monographs of the 89th Scientific Congress & Annual Meeting of Formosan Medical Association. Taipei. 1996.
25. Pindborg JJ, Bhonsle RB, Murti RR, et al. Incidence rate and early forms of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1980;50:40-4.
26. Seedat HA, van Wyk CW. Betel chewing and dietary habits of chewers without and with submucous fibrosis and with concomitant oral cancer. 5 Afr Med J 1988;74:572-5.
27. Cannif JP, Batchelor JR, Dodi IA, Harvey W. HLA-typing in oral submucous fibrosis. Tissue Antigens 1985;26:138-42.
28. Van Wky CW, Grobler-Rabie AF, Martell RW, Hammond MG. HLA-antigen in oral submucous fibrosis. J Oral Pathol Med 1994;23:23-7.